[ad_1]
PROVIDED: French Finance Minister Agnès Pannier-Runacher, photographed here in October 2018. Photo: Blondet Eliot / ABACA
The French finance minister calls it unacceptable that the pharmaceutical company Sanofi said on Wednesday that the United States would first receive a possible covid-19 vaccine.
The French company will be among the ten largest pharmaceutical companies in the world. According to Pharma Letter, they estimated sales of $ 27.77 billion in 2019.
On Wednesday, CEO Paul Hudson told Bloomberg News that Americans would likely receive the vaccine first if they manage to produce it.
“The United States government is entitled to the largest advance reserve because it invested in taking the risk,” he said.
In February, the United States will have expanded its existing partnership with Sanofi to develop a possible vaccine.
According to Bloomberg, Hudson said the United States “looks forward to receiving the doses first as they were at risk of helping them develop the doses.”
also read
Various antibody tests along the way: – This really has a lot to say
According to Hudson, there will be an advantage in everything from days to weeks.
– I have been campaigning in Europe to tell you that the United States will receive the vaccines first. That will be the case as they have invested in trying to protect their people and reopen their economy, the CEO said Wednesday.
On Thursday, Sanofi communicated and stated that a vaccine will be available to everyone, according to Reuters.
CEO: Paul Hudson, CEO of Sanofi photographed in February. Photo: BENOIT TESSIER / REUTERS
The reactions have not failed in France. Finance Minister Agnès Pannier-Runacher told Sud Radio on Thursday, reprinted on Le Monde:
– For us, it is unacceptable that certain countries have privileged access under the pretext of economic conditions.
Pannier-Runacher also says he immediately contacted the pharmaceutical company after hearing Hudson’s statement.
– The head of Sanofi confirmed to me that the vaccine will be available for all countries and, of course, for the French, since they have production capacity in France, he says.
also read
– A vaccine is the only way we can get our normal lives back
Following the reactions in France, according to Le Monde, Sanofi received a statement Wednesday night stating that production on US soil will go primarily to the United States, while production elsewhere will go to France, Europe. and the rest of the world.
On Thursday morning, a French company representative told BFMTV that Sanofi will not grant the United States preferential rights to a possible covid-19 vaccine if the EU proves to be “equally effective” in financing development.
also read
New report: virus can last two years
According to Bloomberg, the US BARDA. USA (A federal agency responsible for vaccine development and treatment for various public health threats, journal. Notes) has so far provided $ 30 million to one of Sanofi’s vaccine projects.
Sonofi and British competitor GlaxoSmithKline are collaborating on the US-backed vaccine project. Together, they believe they can produce 600 million doses annually, a capacity that Hudson aims to double. They plan to start human testing in the second half of 2020 and hope to have a vaccine ready in the second half of 2021.
According to Bloomberg, at least 100 other vaccine projects are being developed in various countries.
In March, it sparked reactions in Germany when Die Welt wrote that United States President Donald Trump, according to German government sources, must have tried to attract the CureVac company, which is also working to develop a crown vaccine, to United States. According to the newspaper, the lure was a considerable sum of money for the company.
The reason should be that Trump wanted to assure the United States of the results of the scientists’ work, “but also only the United States.”
